Recommendations For Eli Lilly and Company
Eli Lilly and Company (LLY.N) (New York Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | December | 25 Nov 2009 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 3 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 10 | 11 | 10 | 10 |
| (4) UNDERPERFORM | 4 | 4 | 5 | 5 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 3.06 | 3.05 | 3.11 | 3.00 |
Market Update
India
US
UK- Asia
- Most Actives
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.61 | -1.11% | 11/25 01:59 IST |
| Gold | 1168.8 | +0.35% | 11/25 01:39 IST |
